Faes Farma SA (FAE.MC)

FAE.MC on Madrid SE C.A.T.S.

2.52EUR
5:02am EDT
Change (% chg)

€-0.00 (-0.20%)
Prev Close
€2.52
Open
€2.50
Day's High
€2.53
Day's Low
€2.50
Volume
39,716
Avg. Vol
349,194
52-wk High
€2.60
52-wk Low
€1.61

FAE.MC

Chart for FAE.MC

About

Faes Farma SA is a Spain-based company engaged in the pharmaceutical industry. The Company specializes in the research, production, distribution and sale of prescription and generic drugs, over-the-counter medicines and personal care treatments, as well as raw materials for the pharmaceutical use. The Company’s research lines... (more)

Overall

Beta: 1.12
Market Cap(Mil.): €624.75
Shares Outstanding(Mil.): 247.92
Dividend: 0.01
Yield (%): 3.12

Financials

  FAE.MC Industry Sector
P/E (TTM): 22.22 37.25 40.68
EPS (TTM): 0.11 -- --
ROI: 10.70 16.52 15.78
ROE: 11.69 17.30 16.82
Search Stocks

BRIEF-Faes Farma H1 net profit rises to 15.6 mln euros

* Says H1 net sales 105.0 million euros ($116.1 million) versus 96.3 million euros year ago

28 Jul 2015

BRIEF-Faes Farma to pay complementary dividend of 0.015 euro gross per share

* To pay FY 2014 complementary dividend of 0.015 euro ($0.0168) gross per share on July 1 Source text for Eikon:

24 Jun 2015

BRIEF-Faes Farma signs deal to create joint venture in China

* Signs deal with Eddingpharm (China) to create a joint venture in China

01 Jun 2015

BRIEF-Faes Farma says bilastine is ready for registration process in Japan

* Says bilastine successfully completed two clinical pivotal studies of phase III in Japan

25 May 2015

BRIEF-Faes Farma reaches license agreement for its product in USA

* Says under license agreement to manufacture and export finished product for its marketing by Marathon Pharmaceuticals in the United States

18 May 2015

BRIEF-Faes Farma Q1 net profit rises to 6.8 mln euros

* Q1 revenue 51.4 million euros ($58.56 million) versus 47.5 million euros year ago

14 May 2015

BRIEF-Faes Farma to increase capital by 486,109 euros

* Says to increase capital by 486,109 euros ($535,255), via issue of 4.9 million new shares

26 Mar 2015

BRIEF-Faes Farma sees FY 2015 revenue of between 200 mln euros and 205 mln euros

* Sees FY 2015 revenue of between 200 million euros ($220 million) and 205 million euros

24 Mar 2015

BRIEF-Faes Farma FY 2014 EBITDA up to 42.2 mln euros

* FY 2014 EBITDA 42.2 million euros versus 36.2 million euros year ago Source text - http://bit.ly/184sf8s Further company coverage: (Gdynia Newsroom)

27 Feb 2015

BRIEF-Faes Farma H2 net sales up to 95.4 mln euros

* H2 net sales 95.4 million euros ($107.0 million) versus 86.9 million euros year ago

27 Feb 2015

Earnings vs. Estimates

Analyst Research Reports

Report Title Price
Provider : Reuters Investment Profile
$20.00
Provider : Wright Reports
$75.00
Provider : GlobalData
$125.00
Provider : GlobalData
$125.00
Provider : Directors Deals Ltd.
$12.00

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

Search Stocks